The DOI matches its Crossref record; 284 of the 286 references it cites were found in a registry or an index.
Guidelines for the treatment of Alzheimer’s disease from the Italian Association of Psychogeriatrics
Abstract
A committee of experts from the Italian Association of Psychogeriatrics compiled the following report, which was then approved by a Steering Committee (comprising 20 specialists in neurology, psychiatry or geriatrics) from the Association and by two Alzheimer associations representing patients and families: the Italian Association for Alzheimer's Disease and the Italian Federation for Alzheimer's Disease. The report is based on a comprehensive review of the scientific literature on the treatment of Alzheimer's disease, discusses methodological aspects of dementia management, and details the limitations of current therapies. These guidelines are, in general, consistent with the principles of evidence-based medicine; however, for some controversial or poorly investigated issues, the guidelines integrate scientific evidence with experience and opinions from experts working in the clinical setting. In particular, the clinical experience of experts has been used to define recommendations for starting and interrupting pharmacotherapy, and to critically review evidence about the efficacy of non-pharmacological interventions. The principal pharmacotherapeutic interventions covered in the guidelines are acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine, and tacrine) and memantine. The main non-pharmacological interventions reviewed are memory training, reality orientation therapy, and combined non-pharmacological interventions. Other issues covered are opportunities for Alzheimer's disease prevention, various modalities of care, and the treatment of comorbidities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Input from consumers or consumer bodies (e.g., Kidney Health Australia, the Italian Association for Alzheimer's Disease) was explicit in nine guidelines [36, 38, 48–54].”
From Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework (2022) · cites this paper as [53]
In the citing paper
“Four guidelines explicitly mentioned General Practitioners (GPs) as actors in reducing dementia risk [36, 38, 53, 57]; nurses were explicitly mentioned in six guidelines [2, 36, 38, 46, 48, 53].”
From Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework (2022) · cites this paper as [53]
In the citing paper
“Guidelines recommending the management of risk factors typically suggested that healthcare professionals follow existing clinical guidelines for individual risk factors [2, 45, 51–53, 57].”
From Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework (2022) · cites this paper as [53]
In the citing paper
“As Table 2 shows, discussion was the most commonly recommended action, mentioned by all but two guidelines [38, 53].”
From Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework (2022) · cites this paper as [53]
In the citing paper
“It would technically be possible to follow five of the included guidelines without ever mentioning dementia to patients [38, 45, 52–54].”
From Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework (2022) · cites this paper as [53]
In the citing paper
“Three included guidelines were over 10 years old and were either lacking in detail [38, 53] or referred to resources that were no longer available [57].”
From Dementia Risk Reduction in Primary Care: A Scoping Review of Clinical Guidelines Using a Behavioral Specificity Framework (2022) · cites this paper as [53]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,401
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
An active and socially integrated lifestyle in late life might protect against dementia
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00767-7 · Cited by 2,135
Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
Schulz, R., O'Brien, A. T., Bookwala, J., & Fleissner, K. (1995) · The Gerontologist · doi:10.1093/geront/35.6.771 · Cited by 1,765
Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
Doody, R. S., Stevens, J. E., Beck, C., Dubinsky, R., Kaye, J. A., Gwyther, L. P., Mohs, R. C., Thal, L. J., Whitehouse, P. J., DeKosky, S. T., et al. (2001) · Neurology · doi:10.1212/wnl.56.9.1154 · Cited by 1,708
A prospective randomized trial
克, 平., & 昌造, 森. (1995) · Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons) · doi:10.4030/jjcs1979.20.2_191 · Cited by 1,621
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
Rogers, S. L., Farlow, M. R., Doody, R. S., Mohs, R., Friedhoff, L. T., & Donepezil Study Group* (1998) · Neurology · doi:10.1212/wnl.50.1.136 · Cited by 1,618
The Study on Cognition and Prognosis in the Elderly (SCOPE)
Lithell, H., Hansson, L., Skoog, I. G., Elmfeldt, D., Albert Hofman, D., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,419
Wolozin, B. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.10.1439 · Cited by 1,408
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Family Caregiving of Persons With Dementia: Prevalence, Health Effects, and Support Strategies
Schulz, R., & Martire, L. M. (2004) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200405000-00002 · Cited by 1,189
McKeith, I., Del Ser, T., Spano, P., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R., & Spiegel, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03399-7 · Cited by 1,182
Cummings, J. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmra040223 · Cited by 1,152
A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease
Knapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,000
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease
Mulnard, R. A., Cotman, C. W., Kawas, C. H., van Dyck, C. H., Sano, M. C., Doody, R. S., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 989
(2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1069 · Cited by 988
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966
Rosler, M., Anand, R., Cicin-Sain, A., Gauthier, S., Agid, Y., Dal-Bianco, P., Stahelin, H. B., Hartman, R., Gharabawi, M., & Bayer, T. (1999) · BMJ · doi:10.1136/bmj.318.7184.633 · Cited by 943
Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays-Grudo, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 939
A 5-month, randomized, placebo-controlled trial of galantamine in AD
Tariot, P. N., Solomon, P. R., Morris, J. C., Kershaw, P. R., Lilienfeld, S., Ding, C., & the Galantamine USA- Study Group (2000) · Neurology · doi:10.1212/wnl.54.12.2269 · Cited by 915
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia: A Review of the Evidence
Sink, K. M., Holden, K. F., & Yaffe, K. (2005) · JAMA · doi:10.1001/jama.293.5.596 · Cited by 910
(2004) · The Lancet · doi:10.1016/s0140-6736(04)16499-4 · Cited by 892
Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia
Spector, A. E., Thorgrimsen, L., Woods, B. T., Royan, L., Davies, S., Butterworth, M., & Orrell, M. W. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.3.248 · Cited by 880
A Family Intervention to Delay Nursing Home Placement of Patients With Alzheimer Disease
Mittelman, M. S. (1996) · JAMA · doi:10.1001/jama.1996.03540210033030 · Cited by 870
Raskind (2000) · doi:10.1212/wnl.54.12.2261 · Cited by 870
Rogers, S. L. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.9.1021 · Cited by 770
Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., & Damaraju, C. V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08267-3 · Cited by 752
Rogers, S. L., & Friedhoff, L. T. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106895 · Cited by 743
Katz, I. R., Jeste, D. V., Mintzer, J. E., Clyde, C., Napolitano, J. A., Brecher, M., & The Risperidone Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0207 · Cited by 741
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
Winblad, B. G., Engedal, K., Soininen, H. S., Verhey, F. R. J., Waldemar, G., Wimo, A. B., Wetterholm, A.-L., Zhang, R., Haglund, A., Subbiah, P., et al. (2001) · Neurology · doi:10.1212/wnl.57.3.489 · Cited by 721
Barker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 714
Finkel, S. I., Miller, S., Silva, J. C. E., Cohen, G. D., & Sartorius, N. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297003943 · Cited by 651
A Controlled Trial of Tacrine in Alzheimer's Disease
Farlow, M. R. (1992) · JAMA · doi:10.1001/jama.268.18.2523 · Cited by 632
A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
Davis, K. L., Thal, L. J., Gamzu, E. R., Davis, C. S., Woolson, R. F., Gracon, S. I., Drachman, D. A., Schneider, L. S., Whitehouse, P. J., Hoover, T. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271801 · Cited by 626
Wilcock, G. K., Lilienfeld, S., & Gaens, E. (2000) · BMJ · doi:10.1136/bmj.321.7274.1445 · Cited by 623
Rethinking the Role of Tube Feeding in Patients with Advanced Dementia
Gillick, M. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420312 · Cited by 620
A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia
Deyn, P. P. D., Rabheru, K., Rasmussen, A. M. L., Bocksberger, J. P., DAUTZENBERG, P. L. J., Eriksson, S., & LAWLOR, B. A. (1999) · Neurology · doi:10.1212/wnl.53.5.946 · Cited by 611
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
Feldman, H., Gauthier, S. G., Hecker, J., Vellas, B. J., Subbiah, P., Whalen, E., & the Donepezil MSAD Study Investigators Group* (2001) · Neurology · doi:10.1212/wnl.57.4.613 · Cited by 600
Street, J. S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.968 · Cited by 585
The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1
Burns, A. S., Rossor, M. N., Hecker, J. R., Gauthier, S. G., Petit, H., Möller, H. ‐., Rogers, S. L., & Friedhoff, L. T. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017126 · Cited by 585
Clare, L., & Woods, B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003260 · Cited by 576
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539
The Magnitude of Dementia Occurrence in the World
Wimo, A. B., Winblad, B. G., Agüero‐Torres, H., & Strauss, E. I. V. (2003) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200304000-00002 · Cited by 536
Rockwood, K. J., Kirkland, S., Hogan, D. B., MacKnight, C., Merry, H. R., Verreault, R., Wolfson, C. M., & McDowell, I. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.223 · Cited by 520
A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients
Mohs, R. C., Doody, R. S., Morris, J. C., Ieni, J. R., Rogers, S. L., Perdomo, C. A., Pratt, R. D., & for the “312” Study Group (2001) · Neurology · doi:10.1212/wnl.57.3.481 · Cited by 502
To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
(2001) · Neurology · doi:10.1212/wnl.57.11.2153-a · Cited by 491
Corey-Bloom, J. (1998) · Medical Entomology and Zoology · Cited by 467
Brodaty, H., Ames, D., Snowdon, J., Woodward, M., Kirwan, J., Clarnette, R., Lee, E., Lyons, B., & Grossman, F. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0205 · Cited by 464
A randomized controlled trial of prednisone in Alzheimer’s disease
Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.3.588 · Cited by 464
A Randomized, Controlled Trial of a Home Environmental Intervention
Gitlin, L. N., Corcoran, M. A., Winter, L., Boyce, A., & Hauck, W. W. (2001) · The Gerontologist · doi:10.1093/geront/41.1.4 · Cited by 452
Janssens, J.-P., & Krause, K. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00931-4 · Cited by 452
Provisional Diagnostic Criteria for Depression of Alzheimer Disease
Olin, J. T., Schneider, L. S. S., Katz, I. R., Meyers, B. S., Alexopoulos, G. S., Breitner, J. C. S., BRUCE, M. L., Caine, E. D., Cummings, J. L., Devanand, D. P., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200203000-00003 · Cited by 426
Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia
Tariot, P. N., Erb, R., Podgorski, C. A., Cox, C., Patel, S., Jakimovich, L., & Irvine, C. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.54 · Cited by 422
Simons, M., Schwärzler, F., Lütjohann, D., von Bergmann, K., Beyreuther, K. T., DICHGANS, J., Wormstall, H., Hartmann, T., & Schulz, J. B. (2002) · Annals of Neurology · doi:10.1002/ana.10292 · Cited by 413
Gill, S. S., Rochon, P. A., Herrmann, N., Lee, P. E., Sykora, K., Gunraj, N., Normand, S.-L. T., Gurwitz, J. H., Marras, C., Wodchis, W. P., et al. (2005) · BMJ · doi:10.1136/bmj.38330.470486.8f · Cited by 402
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398
Ballard, C. G., O'Brien, J. T., Reichelt, K., & Perry, E. K. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0703 · Cited by 396
Donepezil in vascular dementia: A randomized, placebo-controlled study
Wilkinson, D., Doody, R., Helme, R., Taubman, K., Mintzer, J., Kertesz, A., Pratt, R. D., & the Donepezil 308 Study Group* (2003) · Neurology · doi:10.1212/01.wnl.0000078943.50032.fc · Cited by 392
Black, S., Román, G. C., Geldmacher, D. S., Salloway, S., Hecker, J., Burns, A., Perdomo, C., Kumar, D., & Pratt, R. (2003) · Stroke · doi:10.1161/01.str.0000091396.95360.e1 · Cited by 386
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
Scharf, S., Mander, A. G., Ugoni, A., Vajda, F. J. E., & Christophidis, N. (1999) · Neurology · doi:10.1212/wnl.53.1.197 · Cited by 385
Mittelman, M. S., Roth, D. L., Coon, D. W., & Haley, W. E. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.850 · Cited by 385
Reines, S. A., Block, G. A., Morris, J. C., Liu, G., Nessly, M. L., Lines, C. R., Norman, B., & Baranak, C. C. (2004) · Neurology · doi:10.1212/wnl.62.1.66 · Cited by 384
Wilcock, G., M??bius, H. J., & St??ffler, A. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200211000-00005 · Cited by 381
A randomized controlled trial of prednisone in Alzheimer’s disease
Koch, H. J., & Szecsey, A. (2000) · Neurology · doi:10.1212/wnl.55.7.1067 · Cited by 381
Tariot, P. N., Cummings, J. L., Katz, I. R., Mintzer, J. E., Perdomo, C. A., Schwam, E. M., & Whalen, E. (2001) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2001.49266.x · Cited by 373
Gerdner, L. A. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200006190 · Cited by 373
Kanowski, S., Herrmann, W., Stephan, K., Wierich, W., & Hörr, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979544 · Cited by 369
Doody, R. S. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.427 · Cited by 362
Practice parameter: Management of dementia (an evidence-based review)
Oken, B. (2001) · Neurology · doi:10.1212/wnl.57.12.2323 · Cited by 350
Double-blind trial of imipramine in Alzheimer's disease patients with and without depression
Reifler, B. V., Teri, L. L., Raskind, M. A., Veith, R. C., Barnes, R., White, E., & McLean, P. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.1.45 · Cited by 342
Farlow, M., Anand, R., Messina Jr, J., Hartman, R., & Veach, J. (2000) · European Neurology · doi:10.1159/000008243 · Cited by 332
Treatment of agitation in AD: A randomized, placebo-controlled clinical trial
Teri, L., Logsdon, R. G., Peskind, E., Raskind, M., Weiner, M. F., Tractenberg, R. E., Foster, N. L., Schneider, L. S., Sano, M., Whitehouse, P., et al. (2000) · Neurology · doi:10.1212/wnl.55.9.1271 · Cited by 330
Music therapy for people with dementia
Vink, A. C., Bruinsma, M. S., & Scholten, R. J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003477.pub2 · Cited by 329
Using antipsychotic agents in older patients.
Alexopoulos, G. S., Streim, J. E., Carpenter, D., & Docherty, J. P. (2004) · PubMed · Cited by 327
Pollock, B. G., Mulsant, B. H., Rosen, J., Sweet, R. A., Mazumdar, S., Bharucha, A., Marin, R., Jacob, N. J., Huber, K. A., Kastango, K. B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.460 · Cited by 327
Ballard, C. G., Margallo‐Lana, M., Juszczak, E., Douglas, S., Swann, A., Thomas, A. J., O'Brien, J. T., Everratt, A., Sadler, S., Maddison, C., et al. (2005) · BMJ · doi:10.1136/bmj.38369.459988.8f · Cited by 324
Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis
Lane, C. E., & Conroy, M. L. (2022) · Springer eBooks · doi:10.1007/978-3-030-94960-0_53 · Cited by 324
Provisional Diagnostic Criteria for Depression of Alzheimer Disease: Rationale and Background
Olin, J. T., Katz, I. R., Meyers, B. S., Schneider, L. S. S., & Lebowitz, B. D. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200203000-00004 · Cited by 321
Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease
Geldmacher, D., Provenzano, G., McRae, T. D., Mastey, V., & Ieni, J. R. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51306.x · Cited by 313
Provisional Diagnostic Criteria for Depression of Alzheimer Disease
Olin, J. T. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.2.125 · Cited by 313
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
Lanctôt, K. L., Herrmann, N., Yau, K. K., Khan, L. R., Liu, B. A., Loulou, M., & Einarson, T. R. (2003) · PubMed Central · Cited by 303
Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change
Morris, M. C., Evans, D. A., Tangney, C. C., Bienias, J. L., Wilson, R. S., Aggarwal, N. T., & Scherr, P. A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.508 · Cited by 302
Efficacy of donepezil in mild cognitive impairment
Salloway, S., Ferris, S. H., Kluger, A., Goldman, R. S., Griesing, T., Kumar, D., & Richardson, S. (2004) · Neurology · doi:10.1212/01.wnl.0000134664.80320.92 · Cited by 301
Cognitive Intervention in Alzheimer Disease: A Randomized Placebo-Controlled Study
Davis, R. N., Massman, P. J., & Doody, R. S. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200101000-00001 · Cited by 300
Dementia Family Caregiver Training: Affecting Beliefs About Caregiving and Caregiver Outcomes
Hepburn, K. W., Tornatore, J. B., & Ostwald, S. W. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49090.x · Cited by 299
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease
Olazarán, J., Muñiz, R., Reisberg, ., Peña‐Casanova, J., del Ser, T., Cruz-Jentoft, A. J., Serrano, P., Navarro, E., de la Rocha, M. L. G., Frank, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000147478.03911.28 · Cited by 294
Rogers, S. L., & Friedhoff, L. T. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00079-5 · Cited by 293
Coon, D. W., Thompson, L., Steffen, A., Sorocco, K., & Gallagher-Thompson, D. (2003) · The Gerontologist · doi:10.1093/geront/43.5.678 · Cited by 283
Effects of estrogen on cognition, mood, and cerebral blood flow in AD
Wang, P. N., Liao, S. Q., Liu, R. S., Liu, C. Y., Chao, H. T., Lu, S. ‐., Yu, H., Wang, S. J., & Liu, H. C. (2000) · Neurology · doi:10.1212/wnl.54.11.2061 · Cited by 280
Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial
Rockwood, K. J. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.5.589 · Cited by 277
Gitlin, L. N., Winter, L., Corcoran, M., Dennis, M. P., Schinfeld, S., & Hauck, W. W. (2003) · The Gerontologist · doi:10.1093/geront/43.4.532 · Cited by 271
Rogers, S. L., Doody, R. S., Pratt, R. D., & Ieni, J. R. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00067-5 · Cited by 268
Gastrostomy Placement and Mortality Among Hospitalized Medicare Beneficiaries
Grant, M. D. (1998) · JAMA · doi:10.1001/jama.279.24.1973 · Cited by 266
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard‐Andersen, L., Gylding‐Sabroe, J., Kristensen, M., Refsum, H. ‐., Öfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258
Efficacy of Donepezil in Early-Stage Alzheimer Disease
Seltzer, B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1852 · Cited by 256
Marriott, A., Donaldson, C., Tarrier, N., & Burns, A. S. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.176.6.557 · Cited by 249
King, A. C., Baumann, K., O'Sullivan, P., Wilcox, S., & Castro, C. M. (2002) · The Journals of Gerontology Series A · doi:10.1093/gerona/57.1.m26 · Cited by 243
The Effects of a Special Computer Network on Caregivers of Persons with Alzheimer??s Disease
BRENNAN, P. F., MOORE, S. M., & SMYTH, K. A. (1995) · Nursing Research · doi:10.1097/00006199-199505000-00007 · Cited by 242
The impact of music therapy on language functioning in dementia
Brotons, M., & Koger, S. M. (2000) · Journal of Music Therapy · doi:10.1093/jmt/37.3.183 · Cited by 237
Devanand, D. P., Marder, K. S., Michaels, K. S., Sackeïm, H. A., Bell, K. L., Sullivan, M. A., Cooper, T. B., Pelton, G. H., & Mayeux, R. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1512 · Cited by 236
Music therapy for people with dementia
Parker, D., Balil-Lozoya, T., Rouillon, L., Hodgkinson, B., & Tuckett, A. G. (2013) · Cited by 234
Mahoney, D. F., Tarlow, B. J., & Jones, R. N. (2003) · The Gerontologist · doi:10.1093/geront/43.4.556 · Cited by 234
Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer’s Disease
Gauthier, S. G., Feldman, H., Hecker, J. R., Vellas, B. J., Ames, D. J., Subbiah, P., Whalen, E., & Emir, B. (2002) · International Psychogeriatrics · doi:10.1017/s104161020200858x · Cited by 229
Weight Change in Alzheimer's Disease
White, H. K., Pieper, C. F., Schmader, K. E., & Fillenbaum, G. G. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb00912.x · Cited by 227
USE OF MUSIC to Decrease Aggressive Behaviors in People With Dementia
Clark, M. E., Lipe, A. W., & Bilbrey, M. (1998) · Journal of Gerontological Nursing · doi:10.3928/0098-9134-19980701-05 · Cited by 226
Incidence of Dementia, Alzheimer's Disease, and Vascular Dementia in Italy. The ILSA Study
Carlo, A. D., Baldereschi, M., Amaducci, L. A., Lepore, V. L., Bracco, L., Maggi, S., Bonaiuto, S., Perissinotto, E., Scarlato, G., Farchi, G., et al. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50006.x · Cited by 225
Coping With Dementia: Evaluation of Four Nonpharmacologic Interventions
Quayhagen, M. P., Quayhagen, M., Corbeil, R. R., Hendrix, R. C., Jackson, J. E., Snyder, L., & Bower, D. (2000) · International Psychogeriatrics · doi:10.1017/s1041610200006360 · Cited by 225
Lee, P. E., Gill, S. S., Freedman, M., Bronskill, S. E., Hillmer, M. P., & Rochon, P. A. (2004) · BMJ · doi:10.1136/bmj.38125.465579.55 · Cited by 225
Validation therapy for dementia
Neal, M., & Wright, P. B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001394 · Cited by 219
Cognitive Rehabilitation of Mildly Impaired Alzheimer Disease Patients on Cholinesterase Inhibitors
Loewenstein, D., Acevedo, A., Czaja, S. J., & Duara, R. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200407000-00007 · Cited by 219
Lyketsos, C. G., Leoutsakos, J., Steele, C. D., Kopunek, S., Steinberg, M., Baker, A. S., Brandt, J., & Rabins, P. V. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1686 · Cited by 214
Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease
Wilkinson, D. G., & Murray, J. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.409 · Cited by 212
A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer???s Disease
Wilcock, G. K., Howe, I., Coles, H., Lilienfeld, S., Truyen, L., Zhu, Y., & Bullock, R. A. (2003) · Drugs & Aging · doi:10.2165/00002512-200320100-00006 · Cited by 211
van Gool, W. A., Weinstein, H. C., Scheltens, P., & Walstra, G. J. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05623-9 · Cited by 210
Placebo-Controlled Study of Divalproex Sodium for Agitation in Dementia
Porsteinsson, A. P., Tariot, P. N., Erb, R., Cox, C., Smith, E., Jakimovich, L. J., Noviasky, J. A., Kowalski, N., Holt, C. J., & Irvine, C. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200102000-00009 · Cited by 206
Cognitive stimulation of patients with dementia: Preliminary results
Breuil, V., de Rotrou, J., Forette, F., Tortrat, D., Ganansia‐Ganem, A., Frambourt, A., Moulin, F., & Boller, F. (1994) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.930090306 · Cited by 204
Quality of Life measures for dementia.
Ready, R. E., & Ott, B. R. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-11 · Cited by 204
Feldman, H., Gauthier, S. G., Hecker, J. R., Vellas, B. J., Emir, B., Mastey, V., Subbiah, P., & The Donepezil MSAD Study Investigators Group (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51260.x · Cited by 202
Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study
Holmes, C., Hopkins, V., Hensford, C., MacLaughlin, V., Wilkinson, D., & Rosenvinge, H. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.593 · Cited by 202
Baker, R., Bell, S., Baker, E., Holloway, J., Pearce, R., Dowling, Z., Thomas, P., Assey, J., & Wareing, L. (2001) · British Journal of Clinical Psychology · doi:10.1348/014466501163508 · Cited by 200
Meehan, K. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00365-7 · Cited by 198
Deyn, P. P. D., Carrasco, M. M., Deberdt, W. G., Jeandel, C., Hay, D. P., Feldman, P. D., Young, C. A., Lehman, D. L., & Breier, A. F. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1032 · Cited by 198
Primary Care Interventions for Dementia Caregivers: 2-Year Outcomes From the REACH Study
Burns, R. A., Nichols, L. O., Martindale-Adams, J. L., Graney, M. J., & Lummus, A. (2003) · The Gerontologist · doi:10.1093/geront/43.4.547 · Cited by 193
Reality Orientation and Reminiscence Therapy
Baines, S. S., Saxby, P. J., & Ehlert, K. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.2.222 · Cited by 192
(1997) · International Journal of Epidemiology · doi:10.1093/ije/26.5.995 · Cited by 189
DONGEN, M. C. J. M. V., van Rossum, E., Kessels, A. G. H., Sielhorst, H., & Knipschild, P. G. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb02589.x · Cited by 186
A Randomized Trial of Family Caregiver Support in the Home Management of Dementia
Mohide, E. A., Pringle, D. M., Streiner, D. L., Gilbert, J. R., Muir, G., & Tew, M. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb03544.x · Cited by 184
Cummings, J. L., Schneider, L. S., Tariot, P. N., Kershaw, P. R., & Yuan, W. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.532 · Cited by 183
Homma, A., Takeda, M., Imai, Y., Udaka, F., Hasegawa, K., Kameyama, M., & Nishimura, T. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017259 · Cited by 179
Saltvedt, I. T., Mo, E.-S. O., Fayers, P. M., Kaasa, S., & Sletvold, O. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50202.x · Cited by 179
Randomized pilot study of nimesulide treatment in Alzheimer’s disease
Aisen, P. S. S., Schmeidler, J., & Pasinetti, G. M. (2002) · Neurology · doi:10.1212/wnl.58.7.1050 · Cited by 179
Quality of life in dementia—a one‐year follow‐up study
Selwood, A., Thorgrimsen, L., & Orrell, M. W. (2005) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1271 · Cited by 177
Petracca, G., Tesón, A., Chemerinski, E., Leiguarda, R. C., & STARKSTEIN, S. E. (1996) · Journal of Neuropsychiatry · doi:10.1176/jnp.8.3.270 · Cited by 174
Sparks, D. L., Lopez, J., Connor, D. J., Sabbagh, M. N., Seward, J., & Browne, P. J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:407 · Cited by 165
Bars, P. L. L., Kieser, M., & Itil, K. Z. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017242 · Cited by 164
Olin, J. T., Fox, L. S., Pawluczyk, S., Taggart, N. A., & Schneider, L. S. (2001) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200111000-00008 · Cited by 163
Burgio, L. D., Stevens, A. B., Guy, D., Roth, D. L., & Haley, W. E. (2003) · The Gerontologist · doi:10.1093/geront/43.4.568 · Cited by 163
Taragano, F. E., Lyketsos, C. G., Mangone, C. A., Allegri, R., & Díaz, E. C. (1997) · Psychosomatics · doi:10.1016/s0033-3182(97)71461-0 · Cited by 162
Wilkinson, D. G., Passmore, A. P., Bullock, R. M., Hopker, S. W., Smith, R. C., Potocnik, F. C. V., Maud, C., Engelbrecht, I., Hock, C., Ieni, J. R., et al. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11294.x · Cited by 158
Kumar, V., Anand, R., Messina, J. C., Hartman, R. D., & Veach, J. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00046.x · Cited by 158
Dawn–dusk simulation light therapy of disturbed circadian rest–activity cycles in demented elderly
Gasio, P. F. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00164-x · Cited by 156
van Dongen, M. C. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00003-9 · Cited by 155
Whitehead, A., Perdomo, C. A., Pratt, R. D., Birks, J., Wilcock, G. K., & Evans, J. G. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1133 · Cited by 154
Hébert, R., Lévesque, L., Vézina, J., Lavoie, J.-P., Ducharme, F., Gendron, C., Préville, M., Voyer, L., & Dubois, M. (2003) · The Journals of Gerontology Series B · doi:10.1093/geronb/58.1.s58 · Cited by 153
Potentially reversible conditions in 1000 consecutive memory clinic patients
Hejl, A. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.4.390 · Cited by 153
Reimer, M. A., Slaughter, S., Donaldson, C., Currie, G., & Eliasziw, M. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52304.x · Cited by 152
Finkel, S. I., Mintzer, J. E., Dysken, M. W., Krishnan, K., Burt, T., & McRae, T. D. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.998 · Cited by 149
A Dyadic Remediation Program for Care Recipients with Dementia
Quayhagen, M. P., Quayhagen, M., Corbeil, R. R., ROTH, P. A., & Rodgers, J. A. (1995) · Nursing Research · doi:10.1097/00006199-199505000-00005 · Cited by 149
Katona, C., Hunter, B. N., & Bray, J. (1998) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199802)13:2 · Cited by 148
Petracca, G., Chemerinski, E., & STARKSTEIN, S. E. (2001) · International Psychogeriatrics · doi:10.1017/s104161020100761x · Cited by 148
Volicer, L., Collard, A. F., Hurley, A. C., Bishop, C. E., Kern, D. C., & Karon, S. L. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06856.x · Cited by 144
Magai, C., Kennedy, G., Cohen, C. I., & Gomberg, D. (2000) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200002000-00009 · Cited by 143
Alzheimer’s disease: Insights from epidemiology
McDowell, I. (2001) · Aging Clinical and Experimental Research · doi:10.1007/bf03351474 · Cited by 140
Efficacy and Safety of Neuroleptics in Behavioral Disorders Associated With Dementia
Lanctôt, K. L., Best, T. S., Mittmann, N., Liu, B. A., OH, P. I., Einarson, T. R., & Naranjo, C. A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1010 · Cited by 136
Minett, T., Thomas, A. J., Wilkinson, L., Daniel, S., Sanders, J., Richardson, J. L., Littlewood, E., Myint, P., Newby, J., & McKeith, I. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.995 · Cited by 136
Effect of Light on Agitation in Institutionalized Patients With Severe Alzheimer Disease
Ancoli‐Israel, S., Martin, J. L., Gehrman, P., Shochat, T., Corey‐Bloom, J., Marler, M., Nolan, S., & Levi, L. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200303000-00010 · Cited by 134
Politis, A., Vozzella, S., Mayer, L. S., Onyike, C., Baker, A. S., & Lyketsos, C. G. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1215 · Cited by 132
Tekin, S., Fairbanks, L. A., O'Connor, S. M., Rosenberg, S., & Cummings, J. L. (2001) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200102000-00013 · Cited by 129
Effects of Music on Alzheimer Patients
LORD, T. R., & Garner, J. E. (1993) · Perceptual and Motor Skills · doi:10.2466/pms.1993.76.2.451 · Cited by 128
Kanowski, S., & Hoerr, R. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-45117 · Cited by 127
Dwolatzky, T., BEREZOVSKI, S., Friedmann, R., Paz, J., Clarfield, A. M., Stessman, J., HAMBURGER, R., Jaul, E., Friedlander, Y., Rosin, A. J., et al. (2001) · Clinical Nutrition · doi:10.1054/clnu.2001.0489 · Cited by 127
Ditzler, K. (1991) · PubMed · Cited by 126
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?
Winblad, B. G., Brodaty, H., Gauthier, S. G., Morris, J. C., Orgogozo, J., Rockwood, K. J., Schneider, L. S. S., Takeda, M., Tariot, P. N., & Wilkinson, D. G. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.496 · Cited by 125
Akkerman, R. L., & Ostwald, S. K. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900202 · Cited by 124
Effects of Supporting Community‐Living Demented Patients and Their Caregivers: A Randomized Trial
Eloniemi-Sulkava, U. R., Notkola, I.-L. K., Hentinen, M., Kivelä, S., Sivenius, J., & Sulkava, R. O. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49255.x · Cited by 123
A nursing intervention to decrease depression in family caregivers of persons with dementia
Buckwalter, K. C., Gerdner, L. A., Kohout, F. J., Hall, G. R., Kelly, A. W., Richards, B. S., & Sime, M. (1999) · Archives of Psychiatric Nursing · doi:10.1016/s0883-9417(99)80024-7 · Cited by 123
Influence of anosognosia on treatment outcome among dementia patients
Attix, D. K., Welsh-Bohmer, K. A., & Schmechel, D. E. (2001) · Neuropsychological Rehabilitation · doi:10.1080/09602010042000097 · Cited by 123
Görtelmeyer, R., & Erbler, H. C. (1992) · PubMed · Cited by 122
Jones, R. W., Soininen, H. S., Häger, K., Aarsland, D., Passmore, P., Murthy, A. K., Zhang, R., & Bahra, R. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1038 · Cited by 118
Tariot, P. N., Schneider, L. S. S., Mintzer, J. E., Cutler, A. J., Cunningham, M. R., Thomas, J. W., & Sommerville, K. W. (2001) · Current Therapeutic Research · doi:10.1016/s0011-393x(01)80042-4 · Cited by 118
Huang, H., Shyu, Y. L., Chen, C.-F., Chen, S., & Lin, L. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.835 · Cited by 116
Lyketsos, C. G., Gonz�lez-Salvador, T., Chin, J. J., Baker, A. S., Black, B. S., & Rabins, P. V. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.796 · Cited by 116
Sival, R. C., Haffmans, P. M. J., Jansen, P. A. F., Duursma, S. A., & Eikelenboom, P. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.653 · Cited by 115
Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial
Smallwood, J., Brown, R., Coulter, F., Irvine, E., & Copland, C. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.473 · Cited by 115
Groene, R. W. (1993) · Journal of Music Therapy · doi:10.1093/jmt/30.3.138 · Cited by 112
Wimo, A. B., Winblad, B. G., Engedal, K., Soininen, H. S., Verhey, F. R. J., Waldemar, G., Wetterholm, A.-L., Mastey, V., Haglund, A., Zhang, R. H., et al. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000066669 · Cited by 112
Prevention of Weight Loss in Dementia with Comprehensive Nutritional Treatment
Keller, H., Gibbs-Ward, A. J., Boudreau, L. D., Goy, R. E., Pattillo, M. S., & Brown, H. M. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1365-2389.2003.51307.x · Cited by 111
Reality Orientation and Dementia: A Controlled Trial of Two Approaches
Hanley, I. G., McGuire, R., & Boyd, W. D. (1981) · The British Journal of Psychiatry · doi:10.1192/bjp.138.1.10 · Cited by 111
Cahn, D. A., Malloy, P. F., Rebok, G. W., & Ott, B. R. (2003) · Applied Neuropsychology · doi:10.1207/s15324826an1004_3 · Cited by 110
Long-Term Effects of Phosphatidylserine, Pyritinol, and Cognitive Training in Alzheimer's Disease
Heiß, W.-D., Kessler, J., Mielke, R., Szelies, B., & Herholz, K. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106702 · Cited by 107
THE PSYCHOLOGICAL SYMPTOMS OF CONJUGAL BEREAVEMENT IN ELDERLY MEN OVER THE FIRST 13 MONTHS
Byrne, G. J., & Raphael, B. (1997) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199702)12:2 · Cited by 106
Donepezil for behavioural disorders associated with Lewy bodies: a case series
Lanctôt, K. L., & Herrmann, N. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200004)15:4 · Cited by 105
Wlodarczyk, J. H., Brodaty, H., & Hawthorne, G. (2004) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2003.12.004 · Cited by 105
Clark, W. S., Street, J. S., Feldman, P. D., & Breier, A. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0108 · Cited by 101
Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., & Hörr, R. (1997) · Phytomedicine · doi:10.1016/s0944-7113(97)80021-9 · Cited by 99
Farlow, M. R., Hake, A. M., Messina, J. C., Hartman, R. D., Veach, J., & Anand, R. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.417 · Cited by 97
Friedhoff, L. T., Cullen, E. I., Geoghagen, N. S. M., & Buxbaum, J. D. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002310 · Cited by 97
Boey (1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1099-1166(199908)14:8 · Cited by 95
The Impact of Validation Group Therapy on Nursing Home Residents With Dementia
Toseland, R. W., Diehl, M., Freeman, K., Manzanares, T., Naleppa, M. J., & McCallion, P. (1997) · Journal of Applied Gerontology · doi:10.1177/073346489701600102 · Cited by 94
The effects of light therapy on mini-mental state examination scores in demented patients
Graf, A., Wallner, C., Schubert, V., Willeit, M., Wlk, W., Fischer, P. A., Kasper, S. F., & Neumeister, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01178-7 · Cited by 93
Gauthier, S. G., Feldman, H., Hecker, J. R., Vellas, B. J., Emir, B., Subbiah, P., & on Behalf of The Donepezil MSAD Study Investigators’ Group (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125001029 · Cited by 84
Research works printed but not linked: 14
- Lanct??t, 2003, CMAJ, 169, 557
- Corey-Bloom, 1998, Int J Geriatr Psychopharmacol, 1, 55
- Ditzler, 1991, Arzneimittelforschung, 41, 773
- Gerber, 1991, Hosp Community Psychiatry, 42, 843
- Heiss, 1994, Dementia, 5, 88
- Robb, 1986, Nurs Res, 35, 113
- Rozzini, 2003, Arch Intern Med, 163, 496
- Gil Gregorio, 2003, J Nutr Health Aging, 7, 304
- Buxbaum, 1, Front Biosci 2 Apr, 7, a50
- Knopman, 1985, Minn Med, 68, 687
- Freter, 1998, CMAJ, 159, 657
- Burge, 2003, Schweiz Rundsch Med Prax, 92, 1857
- van Hout, 2000, Br J Gen Pract, 50, 311
- Namazi, 1991, Am J Alzheimer??s Care Relat Disord Res, 6, 3
Cited by
Sorted by citations
O'Brien, J. T., Holmes, C., Jones, M. S., Jones, R. W., Livingston, G., McKeith, I. G., Mittler, P. J., Passmore, P., Ritchie, C. W., Robinson, L. A., et al. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881116680924 · Cited by 361
Efficacy of Music Therapy in the Treatment of Behavioral and Psychiatric Symptoms of Dementia
Raglio, A., Bellelli, G., Traficante, D., Gianotti, M., Ubezio, M. C., Villani, D., & Trabucchi, M. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181630b6f · Cited by 333
“Because of these difficulties, recent guidelines from national and international associations recommend that the pharmacologic approach should not be the first-line treatment.(3,6) Nonpharmacologic approaches are longtime known to be useful in the treatment of BPSD.”
BackgroundSeltzer, B. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.7.1011 · Cited by 260
“Guidelines published in several countries (see for example [170,171]) now recommend the routine use of cholinesterase inhibitors in at least some”
BackgroundAzermai, M., Petrović, M., Elseviers, M. M., Bourgeois, J., Bortel, L. M. V., & Stichele, R. V. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.07.002 · Cited by 197
Santo, S. G. D., Prinelli, F., Adorni, F., Caltagirone, C., & Musicco, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122140 · Cited by 186
Metadata
- Authors
- Caltagirone, C., Bianchetti, A., Luca, M. D., Mecocci, P., Padovani, A., Pirfo, E., Scapicchio, P., Senin, U., Trabucchi, M., & Musicco, M.
- Affiliations
- University of Rome Tor Vergata (IT)
- Gruppo di Ricerca Geriatrica (IT)
- University of Perugia (IT)
- University of Brescia (IT)
- University of Turin (IT)
- Institute of Biomedical Technologies (IT)
- Corresponding author
- Caltagirone, Carlo
- Venue
- Drugs & Aging
- Published
- 2005
- Volume
- 22
- Issue
- Suppl 1
- Pages
- 1???26
- ISSN
- 1170-229X (ISSN-L)
- OpenAlex
- W2057760116
- Cited by
- 55
- References
- 286
- Citations by year
- 2026: 1 · 2025: 2 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 1 · 2019: 1 · 2017: 3 · 2016: 1 · 2015: 2 · 2013: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- Drugs & Aging (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, dementia management, acetylcholinesterase inhibitors, memantine, non-pharmacological treatment, memory training, reality orientation therapy, pharmacotherapy, Alzheimer's disease prevention, comorbidities, treatment guidelines
- MeSH terms
- Aged, Alzheimer Disease, Cholinesterase Inhibitors, Clinical Trials as Topic, Depressive Disorder, Humans, Italy, Memantine, Psychotherapy, Excitatory Amino Acid Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
